EU highlights SenzaGen's animal-free test – the world's first of its kind to assess whether chemical substances can cause respiratory allergies
Today, International Asthma Day is being recognized worldwide. Asthma is a global health problem - over 300 million have a diagnosis and nearly 1 million Swedes are affected – a number expected to increase. The EU has invested in the development of the world's first in-vitro test for respiratory sensitization. GARD®air was developed by the Swedish company SenzaGen and predicts whether chemical substances can cause allergic reactions in the airways. The test, which is based on Artificial Intelligence and Genomics, enables not only development of safe products but also preventative measures –